CTT Pharmaceutical Holdings Overview
Get informed when a big investor buys or sells
+ Follow-43.54
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for CTTH is -43.54. That is below the sector sector average of 27.12. Investors often review this figure alongside CTT Pharmaceutical Holdings's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, CTTH currently prints -43.54 for P/E ratio, while the sector average sits near 27.12. That is roughly 260.6% below the sector mean. Large gaps often invite a closer look at CTT Pharmaceutical Holdings's growth, margins, and balance sheet.
A P/E ratio of -43.54 for CTT Pharmaceutical Holdings is not 'good' or 'bad' on its own. Compare it with the peer average (27.12) and with CTTH's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting CTTH's P/E ratio (-43.54), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
